[Diabetic metabolic disorders in the treatment of leukemia].
D000970:Antineoplastic Agents / Q000009:adverse effects; D001215:Asparaginase / Q000009:adverse effects; D002648:Child; D003920:Diabetes Mellitus / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D008297:Male
D000970:Antineoplastic Agents; D001215:Asparaginase
Diabetische Stoffwechselentgleisung bei Leukämiebehandlung.